ATLASFirst Trust NYSE Arca Biotechnology Index Fund (FBT): outlook, holdings and fees
First Trust NYSE Arca Biotechnology Index Fund (FBT) is an exchange-traded fund and is managed by First Trust. The expense ratio is 0.54% and the yield is 0.00%. The ten largest holdings are 39% of the fund.
Fund data as of Oct 14, 2026 · Price Nov 2, 2026
ATLAS view on FBT
| Last price | $278.55 (-0.6%) |
|---|---|
| ATLAS chance of a higher price in 1 month | 53% |
| Likely 1-month range (50%) | $269.66 – $290.03 |
| Normal 1-day range (±1σ) | ±1.2% |
| Distribution yield | 0.00% |
ATLAS probabilities use the same calibrated model as every stock page. A fair value is shown for companies, not funds; the holdings below link to the fair value of each company.
FBT fund facts
| Issuer | First Trust |
|---|---|
| Theme | Technology & innovation |
| Assets under management | $2.9B |
| Expense ratio | 0.54% |
| Number of holdings | 30 |
| Portfolio turnover | 30% |
| Inception | Jun 19, 2006 |
| Exchange | NYSE |
The fund will normally invest at least 90% of its net assets (including investment borrowings) in the securities that comprise the index. The index is an equal-dollar weighted index designed to measure the performance of 30 leading biotechnology companies.
FBT top holdings
| Holding | Sector | Weight |
|---|---|---|
| Natera Inc NTRA | Healthcare | 4.65% |
| Illumina Inc ILMN | Healthcare | 4.41% |
| Halozyme Therapeutics Inc HALO | Healthcare | 4.32% |
| Corcept Therapeutics Incorporated CORT | Healthcare | 3.95% |
| Genmab AS GMAB | Healthcare | 3.91% |
| Repligen Corporation RGEN | Healthcare | 3.72% |
| BeiGene Ltd BGNE | Healthcare | 3.68% |
| Gilead Sciences Inc GILD | Healthcare | 3.75% |
| NeoGenomics Inc NEO | Healthcare | 3.46% |
| Amgen Inc AMGN | Healthcare | 3.53% |
Holdings with an ATLAS page link to their probability range, fair value and earnings calendar.
FBT sector breakdown
| Sector | Weight |
|---|---|
| Healthcare | 100.0% |
By region: North America 96.0%, Europe Developed 4.0%.
FBT returns and risk
| Year to date | +27.4% |
|---|---|
| 1 year | +41.0% |
| 3 years (annualised) | +21.8% |
| 5 years (annualised) | +10.0% |
| 10 years (annualised) | +10.6% |
| Volatility (3 years) | 19.2% |
| Sharpe ratio (3 years) | 0.94 |
Past returns do not guarantee future results.
FBT: frequently asked questions
What does FBT invest in?
First Trust NYSE Arca Biotechnology Index Fund invests in a portfolio of securities. Its largest holdings are Natera Inc (4.7%), Illumina Inc (4.4%), Halozyme Therapeutics Inc (4.3%), Corcept Therapeutics Incorporated (3.9%), Genmab AS (3.9%).
What is the FBT expense ratio?
0.54% a year: about $54.00 for every $10,000 invested.
What is the FBT dividend yield?
0.00%. ATLAS does not hold the exact distribution dates for ETFs.
Will FBT go up?
Nobody can know. The ATLAS model puts the chance of a higher price in one month at 53%, with a likely range (50%) of $269.66 to $290.03 from $278.55 today. It is a probability, not a prediction.
How has FBT performed?
Year to date +27.4%, one year +41.0%, three years +21.8% a year, five years +10.0% a year. Past returns do not guarantee future results.
Similar ETFs: Technology & innovation
- Vanguard Information Technology ETF (VGT)
- State Street Technology Select Sector SPDR ETF (XLK)
- iShares U.S. Technology ETF (IYW)
- Fidelity MSCI Information Technology Index ETF (FTEC)
- First Trust Nasdaq Cybersecurity ETF (CIBR)
- iShares Expanded Tech-Software Sector ETF (IGV)
- iShares A.I. Innovation and Tech Active ETF (BAI)
- iShares Expanded Tech Sector ETF (IGM)
Educational information, not investment advice. Disclaimer